Variant report

Variant	nsv902376
Chromosome Location	chr14:105066444-105100021
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:185)
CpG islands
(count:733)
Chromatin interactive
region (count:16)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:185 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr14:105070922-105071333	H1-hESC	embryonic stem cell:	n/a	n/a
2	BHLHE40	chr14:105071080-105071347	K562	blood:	n/a	chr14:105071161-105071177
3	BHLHE40	chr14:105071194-105071232	HepG2	liver:	n/a	n/a
4	CCNT2	chr14:105071130-105071365	K562	blood:	n/a	n/a
5	CEBPB	chr14:105084361-105084619	HepG2	liver:	n/a	n/a
6	CEBPB	chr14:105099416-105099420	A549	lung:	n/a	n/a
7	CEBPB	chr14:105071172-105071282	H1-hESC	embryonic stem cell:	n/a	n/a
8	CEBPB	chr14:105099309-105099474	HepG2	liver:	n/a	n/a
9	CHD2	chr14:105070967-105071403	H1-hESC	embryonic stem cell:	n/a	n/a
10	CREB1	chr14:105071022-105071273	A549	lung:	n/a	n/a
11	CTCF	chr14:105094480-105094630	MCF-7	breast:	n/a	n/a
12	CTCF	chr14:105094560-105094710	HepG2	liver:	n/a	n/a
13	CTCF	chr14:105071195-105071244	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTCF	chr14:105097267-105097271	GM13976	blood:	n/a	n/a
15	CTCF	chr14:105094004-105094067	LNCaP	prostate:	n/a	n/a
16	CTCF	chr14:105092232-105092263	Lung_OC	lung:	n/a	n/a
17	CTCF	chr14:105092722-105092801	GM10266	blood:	n/a	n/a
18	E2F4	chr14:105071040-105071381	K562	blood:	n/a	chr14:105071210-105071222 chr14:105071159-105071169 chr14:105071211-105071222
19	E2F6	chr14:105070999-105071396	K562	blood:	n/a	chr14:105071210-105071222 chr14:105071159-105071169 chr14:105071211-105071222
20	E2F6	chr14:105071031-105071401	A549	lung:	n/a	chr14:105071210-105071222 chr14:105071159-105071169 chr14:105071211-105071222
21	E2F6	chr14:105070999-105071277	K562	blood:	n/a	chr14:105071210-105071222 chr14:105071159-105071169 chr14:105071211-105071222
22	E2F6	chr14:105070802-105070970	K562	blood:	n/a	n/a
23	E2F6	chr14:105070827-105071416	A549	lung:	n/a	chr14:105071210-105071222 chr14:105071159-105071169 chr14:105071211-105071222
24	E2F6	chr14:105070424-105071512	H1-hESC	embryonic stem cell:	n/a	chr14:105071210-105071222 chr14:105071159-105071169 chr14:105071211-105071222
25	E2F6	chr14:105070663-105071480	H1-hESC	embryonic stem cell:	n/a	chr14:105071210-105071222 chr14:105071159-105071169 chr14:105071211-105071222
26	E2F6	chr14:105071006-105071304	K562	blood:	n/a	chr14:105071210-105071222 chr14:105071159-105071169 chr14:105071211-105071222
27	ELF1	chr14:105071104-105071334	K562	blood:	n/a	chr14:105071159-105071171
28	ELF1	chr14:105070333-105070644	K562	blood:	n/a	chr14:105070443-105070455 chr14:105070517-105070526 chr14:105070513-105070526
29	ELF1	chr14:105070349-105070619	K562	blood:	n/a	chr14:105070443-105070455 chr14:105070517-105070526 chr14:105070513-105070526
30	ELF1	chr14:105099065-105099352	GM12878	blood:	n/a	n/a
31	EP300	chr14:105068219-105068546	SK-N-SH_RA	brain:	n/a	n/a
32	EP300	chr14:105066453-105066876	SK-N-SH_RA	brain:	n/a	n/a
33	EP300	chr14:105068197-105068576	SK-N-SH_RA	brain:	n/a	n/a
34	ETS1	chr14:105071092-105071238	K562	blood:	n/a	n/a
35	FOS	chr14:105076669-105076677	MCF10A-Er-Src	breast:	n/a	n/a
36	GABPA	chr14:105070628-105071491	H1-hESC	embryonic stem cell:	n/a	chr14:105071194-105071203 chr14:105071192-105071203
37	GABPA	chr14:105070679-105071460	H1-hESC	embryonic stem cell:	n/a	chr14:105071194-105071203 chr14:105071192-105071203
38	GATA2	chr14:105083017-105083230	SH-SY5Y	brain:	n/a	n/a
39	GATA3	chr14:105083026-105083315	SH-SY5Y	brain:	n/a	n/a
40	GATA3	chr14:105071859-105072186	SH-SY5Y	brain:	n/a	n/a
41	GTF2F1	chr14:105071022-105071325	H1-hESC	embryonic stem cell:	n/a	n/a
42	HCFC1	chr14:105071212-105071214	K562	blood:	n/a	n/a
43	HDAC2	chr14:105071100-105071308	K562	blood:	n/a	chr14:105071231-105071250
44	HMGN3	chr14:105071059-105071252	K562	blood:	n/a	n/a
45	JUND	chr14:105071106-105071365	H1-hESC	embryonic stem cell:	n/a	n/a
46	KAP1	chr14:105086780-105087128	HEK293	kidney:	n/a	n/a
47	KAP1	chr14:105095454-105095944	HEK293	kidney:	n/a	n/a
48	KAP1	chr14:105095589-105095946	U2OS	brain:	n/a	n/a
49	MAFK	chr14:105087258-105087458	HepG2	liver:	n/a	n/a
50	MAFK	chr14:105087196-105087474	HepG2	liver:	n/a	n/a

(count:733 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr14:105066731-105066781	A549	lung:	n/a
2	chr14:105066731-105066781	A549	lung:	n/a
3	chr14:105089124-105089174	HRPEpiC	eye:	n/a
4	chr14:105089124-105089174	Jurkat	blood:	n/a
5	chr14:105066731-105066781	SAEC	small airway:	n/a
6	chr14:105071714-105071764	PANC-1	pancreas:	n/a
7	chr14:105066731-105066781	H1-hESC	embryonic stem cell:	embryo
8	chr14:105075280-105075330	HAEpiC	amniotic membrane:	n/a
9	chr14:105070749-105070799	HL-60	blood:	n/a
10	chr14:105070998-105071048	HCPEpiC	choroid plexus:	n/a
11	chr14:105070998-105071048	HUVEC	blood vessel:	n/a
12	chr14:105070864-105070914	HCPEpiC	choroid plexus:	n/a
13	chr14:105070340-105070390	LNCaP	prostate:	n/a
14	chr14:105070998-105071048	HRE	kidney:	n/a
15	chr14:105070749-105070799	Hepatocyte	liver:	n/a
16	chr14:105071714-105071764	HPAEpiC	pulmonary alveolar:	n/a
17	chr14:105070749-105070799	HRPEpiC	eye:	n/a
18	chr14:105070340-105070390	HPAEpiC	pulmonary alveolar:	n/a
19	chr14:105071695-105071745	Hela-S3	cervix:	n/a
20	chr14:105070864-105070914	Jurkat	blood:	n/a
21	chr14:105070749-105070799	A549	lung:	n/a
22	chr14:105071313-105071363	NB4	blood:	n/a
23	chr14:105071382-105071432	LNCaP	prostate:	n/a
24	chr14:105071382-105071432	HPAEpiC	pulmonary alveolar:	n/a
25	chr14:105089100-105089150	Hela-S3	cervix:	n/a
26	chr14:105071714-105071764	LNCaP	prostate:	n/a
27	chr14:105089100-105089150	NHDF-neo	bronchial:	n/a
28	chr14:105070340-105070390	AG10803	skin:	n/a
29	chr14:105066731-105066781	AG09319	gingival:	n/a
30	chr14:105071695-105071745	AG04450	lung:	fetal
31	chr14:105075280-105075330	GM12892	blood:	n/a
32	chr14:105071695-105071745	AG09319	gingival:	n/a
33	chr14:105070749-105070799	BE2_C	brain:	n/a
34	chr14:105070864-105070914	AG09319	gingival:	n/a
35	chr14:105070864-105070914	HCF	heart:	n/a
36	chr14:105070749-105070799	HRCEpiC	kidney:	n/a
37	chr14:105070864-105070914	HRCEpiC	kidney:	n/a
38	chr14:105071695-105071745	PrEC	prostate:	n/a
39	chr14:105071382-105071432	HMEC	breast:	n/a
40	chr14:105070340-105070390	AG04449	skin:	fetal
41	chr14:105070864-105070914	GM12891	blood:	n/a
42	chr14:105071313-105071363	HAEpiC	amniotic membrane:	n/a
43	chr14:105075280-105075330	SK-N-SH	brain:	n/a
44	chr14:105071714-105071764	HEK293	kidney:	embryo
45	chr14:105071382-105071432	MCF10A-Er-Src	breast:	n/a
46	chr14:105071313-105071363	NHBE	bronchial:	n/a
47	chr14:105066731-105066781	AG09309	skin:	n/a
48	chr14:105070749-105070799	RPTEC	kidney:	n/a
49	chr14:105070998-105071048	SKMC	muscle:	n/a
50	chr14:105066731-105066781	AG04449	skin:	fetal

(count:16 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr14:105084423..105086474-chr14:105089188..105091844,2	MCF-7	breast:
2	chr14:105074893..105076947-chr14:105079863..105082631,2	MCF-7	breast:
3	chr14:105074893..105076947-chr14:105079863..105082631,2	MCF-7	breast:
4	chr14:105071154..105074580-chr14:105074693..105076354,3	MCF-7	breast:
5	chr14:104907597..104909438-chr14:105077013..105079589,2	K562	blood:
6	chr14:105099367..105101521-chr14:105102716..105104722,2	MCF-7	breast:
7	chr14:105093513..105095968-chr14:105096544..105098298,2	MCF-7	breast:
8	chr14:105094448..105097291-chr14:105102750..105105343,2	K562	blood:
9	chr14:105056988..105059917-chr14:105095476..105097400,2	MCF-7	breast:
10	chr14:105062889..105065817-chr14:105075857..105078518,2	MCF-7	breast:
11	chr14:105082698..105084896-chr14:105087171..105089277,2	K562	blood:
12	chr14:105093513..105095968-chr14:105096544..105098298,2	MCF-7	breast:
13	chr14:105082698..105084896-chr14:105087171..105089277,2	K562	blood:
14	chr14:105067674..105070275-chr14:105105172..105108009,2	MCF-7	breast:
15	chr14:105084423..105086474-chr14:105089188..105091844,2	MCF-7	breast:
16	chr14:105051460..105054318-chr14:105065676..105068171,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C14orf180-2	chr14:105069237-105069901	ucscGeneNc_uc001yrr_2
2	lnc-C14orf180-2	chr14:105071099-105072888	NONHSAT040264
3	lnc-C14orf180-2	chr14:105070351-105071697	ucscGeneNc_uc001yrr_2

No data

Variant related genes	Relation type
TMEM179	TF binding region
TMEM179	CpG island
ENSG00000258986	chromatin interactions

Extended variants
information (count: 1392 )
Associated
traits (count: 103 )

Variant overlapped rSNPs/rCNVs (count:1392 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4454893	chr14:105066444-105066445	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs561474552	chr14:105066474-105066475	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs139608864	chr14:105066483-105066484	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs71421873	chr14:105066484-105066485	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs537237975	chr14:105066491-105066492	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs530131510	chr14:105066515-105066516	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs557540216	chr14:105066517-105066518	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs187303015	chr14:105066610-105066611	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs142840406	chr14:105066617-105066618	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs552912795	chr14:105066653-105066654	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs151023710	chr14:105066732-105066733	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs529205890	chr14:105066744-105066745	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs113475729	chr14:105066749-105066750	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs140887373	chr14:105066760-105066761	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs575507520	chr14:105066761-105066762	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs544032575	chr14:105066779-105066780	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs560324046	chr14:105066806-105066807	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs75239420	chr14:105066810-105066811	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs71421874	chr14:105066865-105066866	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs7142224	chr14:105066885-105066886	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
21	rs540315706	chr14:105066919-105066920	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs555646900	chr14:105066920-105066921	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs60794775	chr14:105066923-105066924	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
24	rs201350690	chr14:105066925-105066926	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs55928927	chr14:105066927-105066928	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs568010323	chr14:105066931-105066932	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs533880014	chr14:105066935-105066936	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs531236270	chr14:105066940-105066941	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs117996852	chr14:105066941-105066942	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs371825981	chr14:105066942-105066943	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs572258329	chr14:105066950-105066951	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs567862869	chr14:105066960-105066961	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs536480107	chr14:105066962-105066963	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs553049536	chr14:105066970-105066971	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs566666638	chr14:105067001-105067002	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs149736341	chr14:105067021-105067022	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs74712070	chr14:105067041-105067042	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs147829953	chr14:105067058-105067059	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs575421578	chr14:105067067-105067068	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs115145883	chr14:105067110-105067111	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs554602810	chr14:105067123-105067124	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs574664824	chr14:105067226-105067227	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs539233374	chr14:105067256-105067257	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs375453994	chr14:105067345-105067346	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs532254480	chr14:105067353-105067354	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs7146030	chr14:105067373-105067374	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
47	rs182302580	chr14:105067376-105067377	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs4983503	chr14:105067406-105067407	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs531073812	chr14:105067407-105067408	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs371995028	chr14:105067418-105067419	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:103)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	17899364	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Chronic myeloid leukemia	20724749	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Colorectal cancer	16774939	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Neuroblastoma	18923191	CNVD
Barrett''s syndrome	19417022	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
cataract	16735990	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Developmental delay	21147756	CNVD
Cancer	20164920	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Biliary cancer	19435499	CNVD
Follicular lymphoma	20505157	CNVD
Acute lymphoblastic leukemia	20139093	CNVD
Hepatocellular carcinoma	16750200	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Glioblastoma multiforme	21922591	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	22174824	CNVD
Non-small cell lung cancer	18320023	CNVD
Melanoma	17363583	CNVD
Prostate cancer	18632612	CNVD
Congenital heart defect	22367666	CNVD
Developmental delay	22367666	CNVD
Genitourinary abnormalities	22367666	CNVD
Intellectual disability	22367666	CNVD
Microcephaly	22367666	CNVD
Muscularhypotonia	22367666	CNVD
Ocular coloboma	22367666	CNVD
Teratozoospermia	22367666	CNVD
Cervical cancer	21062161	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	21990379	CNVD
Breast cancer	16417655	CNVD
22q11 deletion syndrome	22511897	CNVD
Cancer	21129771	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Schizophrenia	21399695	CNVD
Intracranial ependymoma	16609018	CNVD
Lung adenocarcinoma	17086460	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
14q deletion syndrome	22511897	CNVD
Epilepsy	22083797	CNVD
Urothelial carcinoma	21177765	CNVD
Ovarian cancer	21720365	CNVD
Cancer	17440070	CNVD
Neurocytoma	17123091	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Central neurocytomas	17123091	CNVD
Acute lymphoblastic leukemia	17315016	CNVD
Lung cancer	17086460	CNVD
Mortal	21835882	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	17426248	CNVD
Ependymoma	20639864	CNVD
Breast cancer	20932292	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
T-cell lymphomas	22341440	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:284 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:105060800-105069000	Weak transcription	Fetal Intestine Small	intestine
2	chr14:105063000-105066600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
3	chr14:105063000-105067400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr14:105063800-105070000	Enhancers	Fetal Brain Male	brain
5	chr14:105064000-105067400	Bivalent Enhancer	Fetal Muscle Leg	muscle
6	chr14:105064000-105068600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
7	chr14:105064400-105068600	Enhancers	Cortex derived primary cultured neurospheres	brain
8	chr14:105064600-105067600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
9	chr14:105064800-105068800	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
10	chr14:105065200-105070800	Weak transcription	Right Atrium	heart
11	chr14:105065400-105070000	Weak transcription	Fetal Heart	heart
12	chr14:105066000-105066800	Enhancers	Brain Substantia Nigra	brain
13	chr14:105066000-105069200	Bivalent Enhancer	Placenta	Placenta
14	chr14:105066200-105066800	Bivalent Enhancer	Fetal Stomach	stomach
15	chr14:105066200-105067000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
16	chr14:105066200-105067400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
17	chr14:105066400-105066600	Bivalent Enhancer	Ovary	ovary
18	chr14:105066400-105066800	Flanking Active TSS	Brain Angular Gyrus	brain
19	chr14:105066400-105066800	Flanking Active TSS	Brain Anterior Caudate	brain
20	chr14:105066400-105066800	Flanking Active TSS	Brain Cingulate Gyrus	brain
21	chr14:105066400-105066800	Flanking Active TSS	Brain Hippocampus Middle	brain
22	chr14:105066400-105066800	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
23	chr14:105066400-105067200	Flanking Active TSS	Brain Germinal Matrix	brain
24	chr14:105066400-105067200	Flanking Active TSS	Fetal Brain Female	brain
25	chr14:105066400-105067400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
26	chr14:105066600-105066800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
27	chr14:105066600-105066800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
28	chr14:105066600-105066800	Enhancers	Pancreas	Pancrea
29	chr14:105066600-105066800	Enhancers	Spleen	Spleen
30	chr14:105066800-105067000	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
31	chr14:105066800-105067000	Enhancers	Brain Anterior Caudate	brain
32	chr14:105066800-105067200	Enhancers	Brain Hippocampus Middle	brain
33	chr14:105066800-105067800	Enhancers	Brain Cingulate Gyrus	brain
34	chr14:105066800-105068800	Enhancers	Brain Inferior Temporal Lobe	brain
35	chr14:105066800-105069400	Enhancers	Brain Angular Gyrus	brain
36	chr14:105066800-105070400	Weak transcription	Pancreas	Pancrea
37	chr14:105067000-105067200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
38	chr14:105067000-105067600	Bivalent Enhancer	Brain Anterior Caudate	brain
39	chr14:105067200-105068200	Enhancers	Brain Germinal Matrix	brain
40	chr14:105067200-105068200	Bivalent Enhancer	Brain Hippocampus Middle	brain
41	chr14:105067200-105069400	Enhancers	Fetal Brain Female	brain
42	chr14:105067400-105068200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr14:105067600-105068000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
44	chr14:105068000-105068200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
45	chr14:105068000-105068600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
46	chr14:105068000-105069800	Weak transcription	Placenta Amnion	Placenta Amnion
47	chr14:105068200-105068400	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
48	chr14:105068200-105068400	Flanking Active TSS	Brain Germinal Matrix	brain
49	chr14:105068200-105068400	Bivalent Enhancer	Fetal Muscle Leg	muscle
50	chr14:105068400-105068800	Enhancers	Brain Germinal Matrix	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links